Transaction by Persons Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 1 August 2014, Leif Johansson, a Director of the Company notified us that, on 1 August 2014, he sold and purchased AstraZeneca PLC Ordinary Shares of $0.25 each. As a result of these transactions, Mr Johansson has increased his total interest by 6,000 AstraZeneca shares. Mr Johansson holds some of his AstraZeneca shares in pension arrangements in Sweden. One part of these arrangements has closed, resulting in the sale of shares. In order to maintain his interest in AstraZeneca shares, Mr Johansson has reinvested the sale proceeds. Details of the sale and purchase are as follows: 1,000 shares sold at a price of SEK 503.00 per share. 1,000 shares purchased at a price of SEK 503.00 per share. In addition, on 1 August 2014, Mr Johansson purchased a further 6,000 shares at a price of SEK 502.95 per share. On 31 July 2014, certain other Directors of the Company notified us that, on 31 July 2014, they purchased AstraZeneca PLC Ordinary Shares of $0.25 each, as follows: Name of Director Number of shares purchased Purchase price Geneviève Berger 300 4324p Shriti Vadera 3,500 4328p John Varley 3,500 4370p A C N Kemp Company Secretary 1 August 2014
Director/PDMR Shareholding Transaction by Persons
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Meta's Bold Plan: Reviving Stablecoins by End of 2026
Of Faded Dreams and New Roads Years back, I watched as Meta tripped over itself trying to launch the Libra project. What a train wreck! That was supposed to be the golden ticket for digital payments. Now, it’s back at it like a dog chasing its tail, with plans to revive stablecoins by the end of 2026 through a partnership with third-party vendors. Feels like we’re...
Continue Reading
Healthcare Bluebook Introduces Innovative GLP-1 Savings Program
Introducing the GLP-1 Savings Strategy Program Healthcare Bluebook has launched its GLP-1 Savings Strategy Program, a practical next step in its Bluebook Rx services. The program is designed to curb pharmacy spending on GLP-1 medications while giving people clearer choices and a simpler path to care. By putting more control in your hands, it aims to make these essential...
Continue Reading
Daniel Sadan Launches 'House of War' Podcast and Events
Introducing the 'House of War' Podcast and Event Series Examining the threat posed by radical Islamism. Daniel Sadan, an influential American businessman and Executive Producer, is thrilled to unveil House of War. This innovative live event and podcast series delves into the global ramifications of the Muslim Brotherhood’s ideology. The concept of "Dar al-Harb" (House...
Continue Reading
Shanghai Electric Drives Clean Energy with New PV Project
Shanghai Electric Expands Renewable Energy Efforts Shanghai Electric has made a significant impact in Romania's clean energy sector by signing its latest photovoltaic project in Parau. This landmark initiative showcases the company's commitment to sustainability and innovation within the renewable energy landscape. Milestone Project Signed with Econergy Recently, the...
Continue Reading
ESGold Corp. Charts Path to Profitable Gold Production
ESGold Corp. and Its Vision for Growth ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is poised to transform its gold production potential into a reality. The company is a standout player in the mining sector, having developed a high-margin operating model that is attractive to investors. With its strategic initiatives in place, ESGold showcases a clear pathway toward...
Continue Reading